Last $8.29 USD
Change Today -0.10 / -1.19%
Volume 379.5K
OSUR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

orasure technologies inc (OSUR) Key Developments

OraSure Technologies, Inc. Revises Earnings Guidance for the Second Quarter of 2014

OraSure Technologies, Inc. revised earnings guidance for the second quarter of 2014. As a result of the $5.5 million payment expected from Roche Diagnostics, the company is reaffirming its projected range of consolidated net revenues of $26.0 to $26.5 million and is now projecting consolidated net income of approximately $0.01 to $0.02 per share for the second quarter of 2014.

OraSure Technologies, Inc. Revises Earnings Guidance for the Second Quarter of 2014

OraSure Technologies, Inc. revised earnings guidance for the second quarter of 2014. For the quarter, the company now expects consolidated net revenues of between $26.0 million and $26.5 million, and a consolidated net loss in the range of $0.08 to $0.09 per share for the second quarter.

OraSure Technologies, Inc. - Shareholder/Analyst Call

To provide an update on certain developments related to its OraQuick(R) HCV business

OraSure Technologies, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-04-2014 10:00 AM

OraSure Technologies, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-04-2014 10:00 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Douglas A. Michels, Chief Executive Officer, President and Director.

OraSure Technologies, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 10:30 AM

OraSure Technologies, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 10:30 AM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States. Speakers: Douglas A. Michels, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $8.29 USD -0.10

OSUR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Momenta Pharmaceuticals Inc $11.73 USD +0.30
Nymox Pharmaceutical Corp $4.64 USD +0.03
Quidel Corp $21.52 USD +0.33
SciClone Pharmaceuticals Inc $5.10 USD +0.06
Trinity Biotech PLC $23.37 USD +0.39
View Industry Companies
 

Industry Analysis

OSUR

Industry Average

Valuation OSUR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.6x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.